Future Bioquantine Programs
Bioquark Inc. has several additional combinatorial Bioquantine programs in development.
Bioquantine – Complex (BQ-Complex) – focused on various areas of “higher order” regeneration and repair dynamics, and the novel biologic and biophysical components required to begin to address such complex cases.
Such programs will integrate Bioquantines with various supporting tools such as scaffolding technologies, bioreactors, and electroceutical technology to fully implement.
These programs include applications in both severe limb amputation and catastrophic wounding.
Bioquantine – DNA (BQ-DNA) – focused on the natural, endogenous gene and chromosomal correction dynamics found extensively throughout regenerative and embryonic tissue niches.
In-vivo reversion to normal of inherited mutations in humans will offer the possibility to address a wide range of genetic and chromosomal diseases.
Bioquantine – AntiViral (BQ-AV) – tapping into the novel mechanisms found in ooplasms and other regenerative micro-environments, for viral silencing, extinction, and symbiogenesis, evolutionarily perfected to protect developing embryos from infection and death.
Embrykinesis – The Future of Biological Age Reversal in Humans
Biological Aging is a physiological measure over time of:
– 1) Fitness (the ability to survive with general health),
– 2) Fertility (the ability to reproduce),
– 3) Robustness (the ability to prevent negative changes from occurring),
– 4) Resilience (the ability to recover from negative changes when the do occur).
The ability to turn back biological time in humans requires all four of these properties to be synergistically addressed.
Bioquark’s Embrykinesis (merging the dynamics of embryogenesis and topokinesis) project represents the first of its kind, integrated approach towards biologic age reversal in humans, which addresses the full biological regulatory architecture of human aging processes, to bring them under complete medical control in the very near future.